Latest Comments

Strong safety and efficacy data position Aerie Pharmaceuticals to submit glaucoma NDA for Roclatan

Strong safety and efficacy data position Aerie Pharmaceuticals to submit glaucoma NDA for Roclatan

Will lampalizumab finally provide a treatment for macular degeneration?

Will lampalizumab finally provide a treatment for macular degeneration?

Gilead looks to maintain dominance in HIV with its novel STR

Gilead looks to maintain dominance in HIV with its novel STR

Arena Pharmaceuticals’ positive topline Phase II results for ralinepag pose threat for J&J’s Uptravi

Arena Pharmaceuticals’ positive topline Phase II results for ralinepag pose threat for J&J’s Uptravi

Hemophilia gene therapies impress, but pricing doubts remain

Hemophilia gene therapies impress, but pricing doubts remain

Merck’s Keytruda stumbles in multiple myeloma

Merck’s Keytruda stumbles in multiple myeloma

Novel Approaches to US Cancer Research Funding on the Horizon

Novel Approaches to US Cancer Research Funding on the Horizon

FDA’s New Price-Tackling Strategy Puts Pressure on the Pharmaceutical Industry

FDA’s New Price-Tackling Strategy Puts Pressure on the Pharmaceutical Industry

EHA 2017: BCl-2 as an Emerging Target for AML

EHA 2017: BCl-2 as an Emerging Target for AML

EHA 2017: New Hope for Multiple Myeloma Patients

EHA 2017: New Hope for Multiple Myeloma Patients

EHA 2017: Novartis is Leading the CAR-T Cell Race

EHA 2017: Novartis is Leading the CAR-T Cell Race

EHA 2017: Targeting the Metabolic Control of the Epigenetic Machinery in R/R AML

EHA 2017: Targeting the Metabolic Control of the Epigenetic Machinery in R/R AML

Pharmaxis’ Bronchitol gears up for new drug application after meeting primary endpoint in phase III trial

Pharmaxis’ Bronchitol gears up for new drug application after meeting primary endpoint in phase III trial

Niche is the new normal: the growth of the orphan drugs market

Niche is the new normal: the growth of the orphan drugs market

Brexit: new alliance hopes to ensure healthcare stability in an uncertain future

Brexit: new alliance hopes to ensure healthcare stability in an uncertain future

COPD severity differs by severity system used

COPD severity differs by severity system used

NeuPSIG 2017: cell therapies may hold the key to opioid use in neuropathic pain

NeuPSIG 2017: cell therapies may hold the key to opioid use in neuropathic pain

EULAR 2017: Big pharma dives back into the lupus pipeline

EULAR 2017: Big pharma dives back into the lupus pipeline

EULAR 2017: Osteoarthritis pipeline product shows promise

EULAR 2017: Osteoarthritis pipeline product shows promise

GSK’s tafenoquine could spell the end for relapsing P. vivax malaria

GSK’s tafenoquine could spell the end for relapsing P. vivax malaria

DEVOTE trial update: ultra long-acting Insulin Tresiba as safe as insulin glargine

DEVOTE trial update: ultra long-acting Insulin Tresiba as safe as insulin glargine